CareSens N-Eco (i-Sens), • CareSens N-Premier (i-Sens), CodeFree (SD Biosensor), GlucoNavii GDH (SD Biosensor)
Diagnostic TestBGM Test
NCT Number: NCT06170515
This study aims to assess analytical performance of four BGMs and four HbA1c POC devices in comparison to suitable comparator or reference methods, with the view to evaluate performance in the hands of trained users, as well as intended users who are unfamiliar with the system (lay users, for BGMs only). System usability will also be assessed for all BGMs (including lancing devices) and HbA1c devices.
Looking for future studies?
Notify Me13 year and older
All sexes
Interventional
Not applicable
Sihanouk Hospital Centre of Hope, Phnom Penh, Cambodia
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Arm 1:
•≥18 years, diagnosed with diabetes
Arm 2:
•≥18 years
Exclusion criteria
Arm 1:
Arm 2:
BGM Test
HbA1c Test
Time frame: 1 year
For BGMs: Performance accuracy is based on ISO 15197 criteria, mean relative bias, 95% limits of agreement, and regression slopes of each BGM with respect to two independently validated comparator BGMs (each investigational BGM will be compared to each comparator BGMs independently).
Time frame: 1 year
For HbA1c: Performance accuracy is based on regression slopes, mean relative bias, 95% limits of agreement, and of each HbA1c device versus the reference method and the concordance between capillary and venous blood results.
Time frame: 1 year
Proportion of label comprehension, system usability and result/symbol interpretation scale rating per question across all lay users stratified by BGM and lancing device; Total system usability score scale per BGM and lancing device.
Time frame: 1 year
Proportion of system usability and result/symbol interpretation scale rating per question across all lay users stratified by BGM and lancing device; Total system usability score scale per BGM and lancing device.
Time frame: 1 year
Proportion of result/symbol interpretation scale rating per question across all lay users stratified by BGM and lancing device; Total system usability score scale per BGM and lancing device
Time frame: 1 year
Number and type of errors observed; proportion of error type observed per BGM and lancing device .
Time frame: 1 year
Number and type of errors observed; proportion of error type observed per BGM and lancing device .
Time frame: 1 year
Proportion of system usability scale rating per question across all healthcare professionals, stratified by HbA1c POC device; Total system usability score scale per HbA1c POC device
Time frame: 1 year
Number and type of errors as displayed on the BGM or HbA1c POC devices, stratified by type of user (BGMs only) and device
Time frame: 1 year
Number and type of errors as displayed on the BGM or HbA1c POC devices, stratified by type of user (BGMs only) and device
Foundation for Innovative New Diagnostics, Switzerland
Other
Performance Evaluation of Blood Glucose Meters and HbA1c Point-of-care Devices
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01035879
Diabetes, Diabetes Mellitus
Los Angeles, California, United States
View Trial DetailsNCT06466837
Behavior, Diabetes
Hong Kong
View Trial DetailsNCT06788743
Confusion, Delirium
Xi’an, Shanxi, China
View Trial DetailsNCT01498276
Cancer, Cardiovascular Diseases
Washington D.C., District of Columbia, United States
View Trial Details